Evidence map›Paper›PMID 33420831›Full record

ArticleJournal of molecular modeling2021

CHARMM force field generation for a cationic thiophene oligomer with ffTK.

Erman Kıbrıs, Nehir Nalıncı Barbak, Nuran Elmacı Irmak

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular modeling, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Erman KıbrısFaculty of Science, Department of Chemistry, İzmir Institute of Technology, 35430, Urla, Izmir, Turkey.
Nehir Nalıncı BarbakFaculty of Science, Department of Chemistry, İzmir Institute of Technology, 35430, Urla, Izmir, Turkey.
Nuran Elmacı IrmakFaculty of Science, Department of Chemistry, İzmir Institute of Technology, 35430, Urla, Izmir, Turkey. nuranelmaci@iyte.edu.tr.ORCID http://orcid.org/0000-0002-9450-2436
Izmir Institute of Technology · TR

Funding

Türkiye Bilimsel ve Teknolojik Araştirma Kurumu 119Z100
6 · The paper itself

Abstract

In the present work, CHARMM force field parameters are generated for a cationic oligomer of N, N, N-trimethyl-3-(4-methylthiophen-3-yl) oxy) propan-1-aminium) which has the potential for sensing biological molecules such as nucleic acids, nucleobases. We have used ffTK (force field tool kit) to obtain potential parameters. MD simulations are performed for 20-mer and its complexes with AMP and ATP. The simulation results are analyzed to see the number of phosphates in adenosine nucleotides effects on the structure of the backbone of oligomer. The UV-VIS calculations for the conformers which possess the most probable radius of gyration are carried out and compared to the experimental ones to validate the generated force field. Graphical Abstract Recent studies have shown that, biologically important anions (ATP, AMP, vb.) change the spectroscopic properties of cationic polythiophenes (CPT) in the solutions. This work aims to generate CHARMM compatible force field parameters for a CPT to explain experimental studies. The type of interactions will be investigated deeply to lead new biosensor studies by examining the formation and the structure of complexes that consist of a oligothiophene and biological molecules, ATP, AMP by molecular dynamic simulations.

Indexed as

Models, MolecularAdenosine MonophosphateAdenosine TriphosphateCationsComputer SimulationHydrogenMolecular ConformationQuantum TheoryThiophenesAdenosine MonophosphateAdenosine TriphosphateCationsHydrogenThiophenesffTKMolecular dynamics simulationPolyelectrolytePolythiophene

Identifiers

PMID33420831
OpenAlexW3120147668

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.